Add BrightSurf on Google Email

Researchers uncover how tumors become resistant to promising p53-targeted therapy

A Mass General Brigham study identifies new mutations that emerge in tumor cells following treatment, driving resistance in patients with different types of cancer. The researchers found two main categories of mutations: those impairing p53 function and others disrupting drug binding, highlighting a path forward for overcoming resistance.

SourceMass General Brigham·JournalCancer Discovery·TypeObservational study·DateJan 12, 2026

Lifesaving breakthrough in bacterial behavior

Researchers have made a groundbreaking discovery about how bacteria swim upstream to cause infections, pointing to new designs for biomedical devices that can prevent contamination. The study found that wider channels with faster counterflows are more prone to invasion, but sharp corner designs can inhibit bacterial growth.

SourceUniversity of Pennsylvania·JournalNewton·TypeExperimental study·DateJan 12, 2026

Health issues linked to cosmetic jab complications

A study by Anglia Ruskin University found that patients with underlying conditions such as type 1 diabetes are at a significantly higher risk of complications from cosmetic botulinum toxin injections. The researchers recommend restricting administration to medically qualified professionals.

SourceAnglia Ruskin University·JournalAesthetic Surgery Journal·TypeSurvey·DateJan 9, 2026

Study: ADRIATIC clinical trial results suggest durvalumab may offer a new path in small cell lung cancer care

A new study suggests that durvalumab may offer a promising treatment option for limited-stage small cell lung cancer patients, extending overall and progression-free survival. However, the therapy's high cost poses significant challenges to sustainability and access in the real-world setting.

SourceUniversity of Miami Miller School of Medicine·JournalJCO Global Oncology·DateJan 9, 2026

Improving sleep isn’t enough: researchers highlight daytime function as key to assessing insomnia treatments

Researchers developed a smartphone-based assessment approach to detect improvements in daytime insomnia symptoms, detecting treatment effects more powerfully than traditional methods. The new method leverages real-time, multimethod assessment and shows potential for personalizing sleep medicine care.

SourceUniversity of Maryland School of Medicine·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateJan 8, 2026

New clinical standards strengthen antimicrobial stewardship in tuberculosis care

The new clinical standards for antimicrobial stewardship in tuberculosis care aim to integrate TB into existing AMS frameworks, strengthening surveillance and resistance monitoring. The standards prioritize effectiveness, safety, and resistance prevention, promoting structured expert consultation services and targeted testing.

SourceGerman Center for Infection Research·JournalIJTLD OPEN·TypeSurvey·DateJan 6, 2026

Mathematicians tame cellular “noise” to control life at the single-cell level

Researchers create a novel mathematical framework to control biological noise, enabling precise single-cell control. The 'Noise Robust Perfect Adaptation' technology suppresses stochastic fluctuations while maintaining stable average behavior, with promising applications in cancer therapy and synthetic biology.

SourceInstitute for Basic Science·JournalNature Communications·TypeComputational simulation/modeling·DateJan 2, 2026

Machine learning drives drug repurposing for neuroblastoma

A study published in EMBO Molecular Medicine has identified a combination of statins and phenothiazines that shows promise in treating aggressive neuroblastoma. The drug combination was found to impede tumour growth and improve survival rates in laboratory trials with mice.

SourceLund University·JournalEMBO Molecular Medicine·TypeComputational simulation/modeling·DateDec 29, 2025

What we can learn from fish calcitonin and its receptor: Evolutionary insights and medical potential

Researchers have identified key mechanisms underlying the evolution of fish calcitonin receptors, which resist desensitization and enable lifelong calcium regulation in marine environments. Designing sCT analogs and developing RAMP-independent CTR agonists may lead to long-acting calcitonin therapies.

SourceShanghai Jiao Tong University Journal Center·JournalLabMed Discovery·TypeNews article·DateDec 28, 2025

Alcohol-related hospitalizations from 2016 to 2022

The study found a significant increase in alcohol-related hospitalizations between 2016 and 2022, with rising mortality rates and extended lengths of stay. Preventive efforts are needed to reduce population-level alcohol consumption and improve treatment outcomes for individuals with alcohol use disorder.

SourceJAMA Network·JournalJAMA Network Open·DateDec 23, 2025

Baveno VII guidelines: shaping the future of portal hypertension management

The Baveno VII consensus guidelines have reshaped portal hypertension management, focusing on early intervention and noninvasive diagnostics. Nonselective beta-blockers and transjugular intrahepatic portosystemic shunt (TIPS) are recommended for clinically significant portal hypertension diagnosis.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeSystematic review·DateDec 19, 2025

Valacyclovir treatment of early symptomatic Alzheimer disease

Researchers found that valacyclovir, an antiviral medication, was ineffective in treating early symptomatic Alzheimer's disease and may even worsen cognitive function. The study suggests that individuals with early symptomatic Alzheimer's disease and herpes simplex virus seropositivity should not be treated with valacyclovir.

SourceJAMA Network·JournalJAMA·DateDec 17, 2025

A platform to test new cancer treatments

Researchers at the University of Geneva have created a laboratory platform to rapidly evaluate the toxicity of new cancer treatments using human tissue-derived cell clusters. This approach allows for safer evaluation and could lead to personalized treatment options.

SourceUniversité de Genève·JournalBiomedicine & Pharmacotherapy·TypeNews article·DateDec 16, 2025

Chinese Neurosurgical Journal study explores the role of a combined therapy in Parkinson’s disease treatment

Researchers investigated a combination of stem cell therapy and BDNF enhancement to treat Parkinson's disease. The strategy aims to promote neuroregeneration and functional recovery by introducing progenitor cells genetically matched to the donors, while upregulating BDNF to mitigate neuronal loss and enhance motor function.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeImaging analysis·DateDec 16, 2025

Researchers show visual training dramatically improves cognitive function after concussion

A new study published in Frontiers in Human Neuroscience reveals that a visual training program called Perceptual Attention Therapy (PATH) produces rapid improvements in reading, attention, memory, and executive function after concussion. PATH addresses underlying visual timing deficits before strengthening specific cognitive skills.

SourceUniversity of California - San Diego·JournalFrontiers in Human Neuroscience·TypeRandomized controlled/clinical trial·DateDec 15, 2025

Population-level trends in ADHD medication prescribing

A repeated cross-sectional study found a significant increase in stimulant prescribing for ADHD, with the largest acceleration observed among female adolescents and young adults aged 18 to 64. The study's findings are consistent with prior research but provide new insights into population-level trends.

SourceJAMA Network·JournalJAMA Network Open·DateDec 11, 2025

Identification of an immuno-inflammatory biomarker in the brain supports potentially more effective personalized treatment for major psychiatric disorders

A study published in Biological Psychiatry identifies a distinct immuno-inflammatory biomarker in the brain linked to immune system dysfunction and poorer response to standard treatments. The findings provide potential value for clinical prediction and precision therapies.

SourceElsevier·JournalBiological Psychiatry·TypeImaging analysis·DateDec 11, 2025

FAU engineers decode dementia type using AI and EEG brainwave analysis

Researchers at Florida Atlantic University have developed a deep learning model that detects and evaluates Alzheimer's disease (AD) and frontotemporal dementia (FTD) using EEG brainwave analysis. The model achieved over 90% accuracy in distinguishing individuals with dementia from cognitively normal participants.

SourceFlorida Atlantic University·JournalBiomedical Signal Processing and Control·TypeComputational simulation/modeling·DateDec 10, 2025

Tuberculosis: Scientists develop novel drug candidate for combating resistant pathogens

Researchers at Martin Luther University Halle-Wittenberg have developed a promising new substance that inhibits the ability of tuberculosis bacteria to produce energy and causes them to die. The compound, PRP020, targets the pathogen's ATP synthase but attacks a different site than existing drugs like bedaquiline.

SourceMartin-Luther-Universität Halle-Wittenberg·JournalJournal of Medicinal Chemistry·TypeExperimental study·DateDec 8, 2025

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A new study presented at ASH 2025 suggests that a virtual program focusing on diet and exercise can help reduce the severity of side effects associated with lymphoma treatment. The program, LIFE-L, showed significant improvements in symptoms such as anxiety, depression, pain, fatigue, and constipation among participants.

New insights into the mechanism of reactive oxygen species in promoting endometriosis progression

Researchers discovered that moderate ROS levels increase cell vitality and resistance to senescence in endometrial stromal cells, contributing to endometriosis progression. Identifying the CHK1/SGK1 axis as a crucial sensor of ROS, the study suggests that targeting this pathway could lead to more effective treatments for endometriosis.

SourceScience China Press·JournalScience Bulletin·DateDec 4, 2025

Antipsychotic medication use by older adults

A growing trend of antipsychotic medication prescription increases in older U.S. adults, with long-term care pharmacies being a primary source. Non-psychiatrist prescribers contribute to the trend, highlighting concerns over medication accessibility and oversight.

SourceJAMA Network·JournalJAMA Psychiatry·DateDec 3, 2025

New technique maps genetic variants driving neurodegenerative disease risk

A new method developed by Penn State researchers improves the analysis of genetic data, identifying more genes associated with neurodegenerative diseases like Alzheimer's and ALS. The technique, BASIC, integrates both bulk tissue samples and single-cell data to uncover shared genetic effects across different cell types.

SourcePenn State·JournalNature Communications·TypeData/statistical analysis·DateDec 2, 2025

American College of Lifestyle Medicine publishes official position on lifestyle medicine as a framework for delivery of high-value, whole-person care

The American College of Lifestyle Medicine has published a position paper calling for the implementation of lifestyle medicine as a scalable and sustainable approach to address chronic disease burden and unsustainable healthcare costs. The framework includes training, board certification, clinical practice toolkits, and numerous resour...

SourceAmerican College of Lifestyle Medicine·JournalAmerican Journal of Lifestyle Medicine·TypeNews article·DateNov 25, 2025